gentamicin has been researched along with isepamicin in 157 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 37 (23.57) | 18.7374 |
1990's | 74 (47.13) | 18.2507 |
2000's | 33 (21.02) | 29.6817 |
2010's | 12 (7.64) | 24.3611 |
2020's | 1 (0.64) | 2.80 |
Authors | Studies |
---|---|
Dinwiddie, CB; Isaacs, LL; Luft, FC; Rankin, LI; Sloan, RS; Yum, MN | 1 |
Goering, RV; Sanders, CC; Sanders, WE | 1 |
Kabins, SA; Nathan, C | 1 |
Barrett, MS; Erwin, ME; Jones, RN; Koontz, FP | 1 |
Hirose, T; Kumamoto, Y; Nishimura, M; Ohya, S; Shibuya, A; Tsukamoto, T | 1 |
Affrime, MB; Awni, WM; Halstenson, CE; Heim-Duthoy, KL; Herman, CS; Keane, WF; Kelloway, JH; Teal, MA; Wong, MO | 1 |
Caminero, MM; Fuentes Martinez, F; Izquierdo Izquierdo, J; Minguez Minguez, F; Prieto Prieto, J | 1 |
Fujimoto, T; Kase, K; Shoshihara, M; Tsuda, Y; Yoshizawa, E | 2 |
Inouye, S; Kettner, M; Miller, GH | 1 |
Igarashi, K; Ikeda, S; Kashiwagi, K; Miyaji, A; Sasakawa, C; Tobe, T | 1 |
Affrime, MB; Awni, WM; Halstenson, CE; Kelloway, JS; Lin, CC; Shapiro, BE; Teal, MA | 1 |
Claes, J; De Broe, ME; Derde, MP; Govaerts, PJ; Kaufman, L; Marquet, JF; Van de Heyning, PH | 1 |
Barrett, MS; Erwin, ME; Johnson, DM; Jones, RN | 1 |
Kuzui, H; Murakami, T; Nishino, T; Obana, Y | 1 |
Blaser, J | 1 |
Feldman, S; Ravis, WR; Van, R; Walterspiel, JN | 1 |
Eto, K; Ishii, T; Kumazawa, J; Matsumoto, T; Saito, Y; Sawae, Y; Ueda, S; Yushita, Y | 1 |
Bamonte, F; Dionisotti, S; Ongini, E; Scaglione, F | 1 |
Agra, M; Lurueña, S; Minguez, F; Prieto, J; Ramos, C | 1 |
Baltch, AL; Ritz, WJ; Smith, RP; Valdes, JM | 1 |
Fujimoto, T; Kase, K; Shoshihara, M; Takao, M; Yoshizawa, E | 1 |
Kumagai, K; Nishibuchi, M; Otsuki, H; Takeda, Y | 1 |
Horiba, M; Nagata, Y; Suzuki, K | 1 |
Bagger-Sjöbäck, D; Harada, Y; Hirakawa, K; Nikaido, M; Nishida, I; Takumida, M | 1 |
Awni, WM; Maloney, JA | 1 |
Katsu, M; Saito, A | 1 |
Hirao, H; Kamiryo, Y; Kato, M; Sanefuji, T | 1 |
Hiraga, Y; Kobayashi, H; Nagahama, F; Nakabayashi, T; Nakayama, I; Onodera, S; Oshitani, H; Saito, A; Sasaki, N; Yoshida, M | 1 |
Endo, K; Katsu, M; Kishi, H; Nakayama, I; Odagiri, S; Saito, A; Takebe, K; Tamura, T; Yoneda, M | 1 |
Aoki, A; Gato, S; Saigusa, M; Shiritani, Y; Tsuji, A; Yamaji, S; Yokoiyama, S | 1 |
Mizuno, A; Nakashima, M; Sato, R; Suzuki, Y; Uematsu, T; Yamazaki, T | 1 |
Hayashi, M; Kinoshita, K; Morishita, M; Nakano, Y; Serizawa, K; Suzuki, T | 1 |
Kobayashi, Y; Oyaide, K; Sono, A; Yamamoto, H | 2 |
Hara, H; Hara, T; Iizuka, K; Matsumoto, K; Morino, T; Motoyama, K; Sano, K; Yamamoto, H | 1 |
Endo, H; Matsumoto, K; Miura, M; Morino, T; Sano, K; Shiraiwa, K; Yamamoto, H | 1 |
Iizuka, K; Matsumoto, K; Miura, M; Morino, T; Nakanishi, D; Sano, K; Yamamoto, H | 1 |
Fujii, H; Matsumoto, K; Miura, M; Morino, T; Shiraiwa, K; Yamamoto, H | 1 |
Kawaguchi, K; Kobayashi, Y; Sasaki, M; Yamada, H; Yamamoto, H | 2 |
Kobayashi, Y; Kubota, H; Suda, M; Yamada, H; Yamamoto, H | 1 |
Kobayashi, Y; Nakano, Y; Niimi, I; Yamamoto, H | 1 |
Kobayashi, Y; Kohira, T; Yamamoto, H; Yano, J | 1 |
Hokonohara, T; Mochizuki, D; Shinoda, Y; Takayanagi, N | 1 |
Kinoshita, H; Mita, I; Nakano, U; Noguchi, M; Shibata, K; Shinoda, Y; Sohmiya, Y; Takayanagi, N; Uzawa, T | 1 |
Endo, S; Morishita, M; Serizawa, K; Shirai, M; Somiya, Y; Suzuki, T | 2 |
Iwasaki, M; Morishita, M; Sakai, A; Shirai, M; Somiya, Y; Suzuki, T | 1 |
Endo, S; Morishita, M; Serizawa, K; Shirai, M; Suzuki, T | 1 |
Endo, S; Morishita, M; Nakanishi, D; Sakai, A; Shirai, M; Somiya, Y; Suzuki, T | 1 |
Iwasaki, M; Morishita, M; Muranishi, S; Serizawa, K; Suzuki, T; Takahashi, T | 3 |
Norden, CW; Schafer, F | 1 |
Bendirdjian, JP; Fillastre, JP; Foucher, B | 1 |
Badal, RE; Baker, CN; Barry, AL; Jones, RN; Packer, RR; Thornsberry, C | 1 |
Barry, AL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Koga, H; Matsumoto, T | 1 |
Chapuis, C; de Montclos, M; Flandrois, JP; Guinet, M | 1 |
Goto, S; Kaneko, Y; Tsuji, A; Yamaguchi, K | 1 |
Deguchi, K; Fukamoto, T; Fukayama, S; Ishihara, R; Koguchi, M; Nakane, Y; Oda, S; Suzuki, Y; Tanaka, S; Yokota, N | 1 |
Godard, C; Hannecart-Pokorni, E; Hubrechts, JM; Maes, P; Nulens, E; Nyssen, HJ; Vanhoof, R; Wildemauwe, C | 1 |
Carbon, C; Farinotti, R; Goldstein, F; Gutmann, L; Mainardi, JL; Mohler, J; Zhou, XY | 1 |
Kobayashi, T; Nakano, S; Nishikawa, S; Ogawa, N; Ohdo, S; Shimada, H; Sugiyama, T; Tomonaga, F; Yoshiyama, Y | 1 |
Kodama, Y; Kuranari, M; Nawata, T; Sakata, T; Sato, Y; Takeyama, M | 1 |
Uematsu, T | 1 |
Affrime, M; Cayen, M; Korduba, C; Lin, CC; Radwanski, E | 1 |
Affrime, M; Batra, V; Cayen, MN; Cutler, D; Korduba, C; Lin, C; Nomeir, A; Radwanski, E | 1 |
Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C | 1 |
Colardyn, F | 1 |
Covi, M; Velluti, G | 1 |
Sturm, W | 1 |
Esparza-Ahumada, S; Morfin-Otero, R; Rodriguez-Noriega, E | 1 |
Giamarellou, H; Pefanis, A; Petrikkos, G; Tsagaraki, C | 1 |
Beaucaire, G | 1 |
Hare, RS; Miller, GH; Naples, L; Sabatelli, FJ; Shaw, KJ | 1 |
Craig, WA | 1 |
Affrime, MB; Barr, WH; Colucci, R; Cutler, D; Elliott, M; Lin, CC; Radwanski, E; Zampaglione, N | 1 |
Affrime, M; Colucci, R; Cutler, D; Elliott, M; Guerciolini, R; Lin, CC; Radwanski, E; Scaglione, F; Viganò, A; Zampaglione, N | 1 |
Jones, RN | 1 |
Bamonte, F; Dionisotti, S; Fredelius, L; Ongini, E; Wersäll, J | 1 |
Carbon, C | 1 |
Blum, D | 1 |
Principi, N; Viganò, A | 1 |
Brasseur, R; Mingeot-Leclercq, MP; Schanck, A; Tulkens, PM; van Bambeke, F | 1 |
Deguchi, K; Fukayama, S; Ishihara, R; Koguchi, M; Oda, S; Suzuki, Y; Tanaka, S | 3 |
Cougnard, J; Minozzi, C; Padoin, C; Petitjean, O; Tod, M | 1 |
Beauchamp, D; Bergeron, MG; Gourde, P; Grenier, L; Labrecque, G; Lin, L; Morin, NJ; Simard, M; Yoshiyama, Y | 1 |
Carbon, C; Caulin, E; Collatz, E; Coutrot, A | 1 |
Affrime, M; Batra, V; Cayen, M; Cutler, D; Korduba, C; Lin, CC; Nomeir, A; Radwanski, E | 1 |
Abe, M; Imaoka, Y; Kamiyama, Y; Kunii, Y; Masamune, R; Momono, S; Oouchi, K; Toyoda, T; Toyoshima, T; Watanabe, I | 1 |
Hilbert, MJ; Korduba, C; Lin, CC; Nomeir, A; Veals, J | 1 |
Affrime, M; Batra, V; Cayen, MN; Christopher, D; Cutler, D; Korduba, C; Lin, CC; Nomeir, AA; Radwanski, E | 1 |
DiGiammarino, EL; Draker, KA; Serpersu, EH; Wright, GD | 1 |
Fuentes, F; Gomez-Lus, ML; Izquierdo, J; Martín, MM; Prieto, J | 1 |
Izard, D; Vachée, A; Vincent, P | 1 |
Iida, H; Kawanabe, K; Matsusue, Y; Nakamura, T; Okada, Y | 1 |
Beauchamp, D; Kanke, M; Yazaki, T; Yoshiyama, Y | 1 |
da Costa, SO; Igarashi, A; Igarashi, K; Kashiwagi, K; Saisho, T; Sakata, K; Tsuhako, MH | 1 |
Aoki, T; Itoh, Y; Itokazu, M; Nishimoto, Y; Nonomura, H | 1 |
Chung, CW; Jun, JH; Kim, KS; Lee, KH; Shim, JC | 1 |
Sato, S; Toriya, M; Tsuji, A; Yamaguchi, S | 1 |
Beaucaire, G; Cougnard, J; Minozzi, C; Petitjean, O; Ponsonnet, D; Tod, M | 1 |
Allaouchiche, B; Boulétreau, P; Breilh, D; Chassard, D; Ducint, D; Jaumain, H; Malbec, I; Saux, MC | 1 |
Endo, K | 1 |
Cumps, J; El Mouedden, M; Laurent, G; Mingeot-Leclercq, MP; Taper, HS; Tulkens, PM | 1 |
Hosino, K; Iwai, Y; Nakamura, A; Nakamura, S; O'Hara, K; Sawai, T; Seto, I | 1 |
Bartsokas, C; Delis, D; Kafetzis, DA; Maltezou, HC; Mavrikou, M; Paraskakis, I; Siafas, C | 1 |
Padoin, C; Petitjean, O; Tod, M | 1 |
Minami, S; Ogake, N; Takahata, M; Yamashiro, Y | 1 |
DeFillipo, K; Reif, V; Vogel, R | 1 |
Hamada, K; Midorikawa, K; Naito, M; Shibata, Y; Yatsunami, M | 1 |
Adinolfi, LE; Andreana, A; Ragone, E; Sarnataro, G; Tripodi, MF; Utili, R | 1 |
DiGiammarino, EL; Ekman, DR; Serpersu, EH; Witter, ED; Wright, E | 1 |
Coulaud, JM; Fauvelle, F; Lecointre, K; Poussel, JF; Tardy, D; Trape, G | 1 |
Chen, YS; Lee, SS; Lin, HH; Lin, WR; Liu, YC; Tsai, TH; Wann, SR; Yen, MY | 1 |
Hashimoto, Y; Kato, M; Liu, M | 1 |
Baka, M; Gombakis, N; Kafetzis, DA; Koliouskas, DE; Kosmidou, H; Malaka-Zafiriou, E; Maltezou, HC | 1 |
Minami, S; Takahata, M; Yamada, H | 1 |
Beauchamp, D; Kanke, M; Wong, P; Yazaki, T; Yoshiyama, Y | 1 |
Allaouchiche, B; Bel, JC; Boselli, E; Breilh, D; Chassard, D; Debon, R; Saux, MC | 1 |
Iyobe, S; Okubo, T | 1 |
Fukushige, T; Kano, T; Sano, T; Ueda, S; Yamada, S | 1 |
Arashima, Y; Kato, K; Kono, K; Ogawa, M; Saito, T; Takeda, S; Watanabe, K | 1 |
Aguiari, G; Banzi, M; Borea, PA; Cai, Y; Del Senno, L; Ferrari, L; Gessi, S; Harris, PC; Lambertini, E; Lanza, F; Manzati, E; Peters, DJ; Piva, R; Somlo, S; Zeggio, E | 1 |
Barinov, SM; Hasegawa, M; Komlev, VS; Sudo, A; Uchida, A | 1 |
Reshed'ko, GK | 1 |
Ha, JS; Jeon, DS; Kim, HC; Kim, JR; Ryoo, NH | 1 |
Avlamis, A; Florentin, I; Giamarellou, H; Grammatikou, M; Pephanis, A; Petrikkos, G | 1 |
Gala, JL; Leal, T; Vandercam, B; Wallemacq, P; Yombi, JC | 1 |
Cheng, NC; Hsueh, PR; Huang, WK; Liu, CY; Liu, YC; Shyr, JM; Teng, LJ | 1 |
Moldavan, IA; Ryzhko, IV; Shcherbaniuk, AI; Smorodinova, IuV | 1 |
Chen, JH; Shen, GH; Wu, BD; Wu, KM | 1 |
Falagas, ME; Kopterides, P | 1 |
Chang, SC; Feng, NH; Hsueh, PR; Tsai, TY; Wang, JT | 1 |
Guo, ZL; He, LX; He, ZG; Liang, YJ; Ren, T; Zhai, XB; Zhang, L; Zheng, YH | 1 |
Denamur, S; Mingeot-Leclercq, MP; Tulkens, PM; Van Bambeke, F | 1 |
Fujita, Y; Horiuchi, R; Hosokawa, S; Nakamura, K; Yamamoto, K | 1 |
Arakawa, S; Fujisawa, M; Shigemura, K; Yamashita, M; Yasufuku, T | 1 |
Chow, JW; Frase, H; Smith, C; Toth, M; Vakulenko, SB | 1 |
Gopal, R; Hahm, JS; Hahm, KS; Jeong, N; Kim, JY; Lee, JK; Park, SC; Park, Y; Son, BK; Yoo, S | 1 |
Bali, R; Das, BK; Kapil, A | 1 |
Cho, B; Im, SA; Park, GS; Yun, DY | 1 |
Falagas, ME; Georgantzi, GG; Karageorgopoulos, DE; Rafailidis, PI; Sun, C; Wang, R | 1 |
Falagas, ME; Karageorgopoulos, DE; Kofteridis, D; Maraki, S; Mavros, MN; Samonis, G | 1 |
Fukunaga, K; Ikeuchi, M; Izumi, M; Kamimoto, Y; Sugimura, N; Takemura, M; Tani, T; Yokoyama, M | 1 |
Falagas, ME; Georgantzi, GG; Kofteridis, DP; Maraki, S; Samonis, G; Vouloumanou, EK | 1 |
Aso, K; Fukunaga, K; Ikeuchi, M; Izumi, M; Kamimoto, Y; Sugimura, N; Tani, T; Yokoyama, M | 1 |
Chang, SC; Ho, MW; Hseuh, PR; Lee, CH; Liu, JW; Liu, JY; Sheng, WH; Wang, FD; Wang, JT | 1 |
Chen, HC; Huang, CC; Huang, WC; Wu, MF | 1 |
Ban, YH; Cha, SS; Hong, SK; Hwang, JY; Kim, HJ; Lee, NJ; Liu, HW; Park, JW; Shin, HL; Song, MC; Yoon, YJ | 1 |
Aoyama, S; Izumi, K; Miyagi, T; Mizokami, A; Nakagawa, R; Nakashima, T; Ofude, M; Shigehara, K; Urata, S | 1 |
Ali, HB; Asuman, B; Kubra, HU; Sarah, AF; Sreylis, N; Yeliz, TC | 1 |
8 review(s) available for gentamicin and isepamicin
Article | Year |
---|---|
[New antimicrobial agents series XXXIV: isepamicin].
Topics: Bacteria; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Gentamicins; Humans; Tissue Distribution | 1989 |
Once-daily versus multiple-daily dosing of aminoglycosides.
Topics: Animals; Anti-Bacterial Agents; Drug Administration Schedule; Gentamicins; Humans | 1995 |
Pharmacokinetics of isepamicin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbohydrate Sequence; Child; Child, Preschool; Gentamicins; Humans; Infant; Infant, Newborn; Middle Aged; Molecular Sequence Data | 1995 |
Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity.
Topics: Anti-Bacterial Agents; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1995 |
An overview of the safety of isepamicin in adults.
Topics: Adult; Aged; Anti-Bacterial Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Creatinine; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Gentamicins; Hearing Disorders; Humans; Kidney Diseases; Liver; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1995 |
Clinical pharmacokinetics and pharmacodynamics of isepamicin.
Topics: Adult; Aging; Animals; Anti-Bacterial Agents; Child; Gentamicins; Humans; Infant, Newborn; Injections, Intramuscular; Injections, Intravenous; Microbial Sensitivity Tests; Tissue Distribution | 2000 |
Old antibiotics for infections in critically ill patients.
Topics: Anti-Bacterial Agents; Chloramphenicol; Critical Illness; Cross Infection; Drug Resistance, Bacterial; Drug Utilization; Fosfomycin; Fusidic Acid; Gentamicins; Humans; Polymyxins | 2007 |
Susceptibility of Gram-negative bacteria to isepamicin: a systematic review.
Topics: Adult; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Databases, Bibliographic; Drug Administration Schedule; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Microbial Sensitivity Tests | 2012 |
26 trial(s) available for gentamicin and isepamicin
Article | Year |
---|---|
Effect of concomitant administration of piperacillin on the dispositions of isepamicin and gentamicin in patients with end-stage renal disease.
Topics: Adult; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; Piperacillin | 1992 |
Treatment of complicated urinary tract infections with ofloxacin following an aminoglycoside.
Topics: Administration, Oral; Adolescent; Aged; Bacteriuria; Drug Therapy, Combination; Gentamicins; Humans; Injections, Intramuscular; Male; Middle Aged; Ofloxacin; Recurrence; Remission Induction; Urinary Tract Infections | 1991 |
[New antimicrobial agents series XXXIV: isepamicin].
Topics: Bacteria; Bacterial Infections; Clinical Trials as Topic; Drug Resistance, Microbial; Gentamicins; Humans; Tissue Distribution | 1989 |
[Clinical trial of HAPA-B in complicated urinary tract infections].
Topics: Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Drug Resistance, Microbial; Enterococcus faecalis; Escherichia coli; Female; Gentamicins; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Serratia marcescens; Urinary Tract Infections | 1986 |
Pharmacokinetics of intravenously administered isepamicin in men.
Topics: Adult; Chromatography, High Pressure Liquid; Electrocardiography; Gentamicins; Half-Life; Humans; Infusions, Intravenous; Male | 1995 |
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Superinfection | 1995 |
The efficacy and safety of isepamicin and ceftazidime compared with amikacin and ceftazidime in acute lower respiratory tract infection.
Topics: Acute Disease; Amikacin; Anti-Bacterial Agents; Bronchitis; Ceftazidime; Cross Infection; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Pneumonia, Bacterial; Respiratory Tract Infections; Retrospective Studies | 1995 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of acute lower respiratory tract infections caused by gram-negative organisms.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bronchitis; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1995 |
Isepamicin versus amikacin in the treatment of urinary tract infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Escherichia coli Infections; Female; Follow-Up Studies; Gentamicins; Humans; Male; Middle Aged; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Urinary Tract Infections | 1995 |
Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Escherichia coli Infections; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Male; Middle Aged; Proteus Infections; Proteus mirabilis; Pseudomonas aeruginosa; Pseudomonas Infections; Skin Diseases, Bacterial; Staphylococcal Skin Infections; Staphylococcus aureus | 1995 |
Evaluation of the efficacy and safety of isepamicin in the treatment of various bacterial infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Drug Administration Schedule; Female; Genital Diseases, Female; Gentamicins; Humans; Male; Middle Aged; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1995 |
Evaluation of the efficacy and safety of isepamicin compared with amikacin in the treatment of nosocomial pneumonia and septicaemia.
Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Cross Infection; Drug Therapy, Combination; Female; Gentamicins; Gram-Negative Bacterial Infections; Humans; Lactams; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies | 1995 |
Overview of the efficacy of isepamicin in the adult core clinical trial programme.
Topics: Abdomen; Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteremia; Drug Administration Schedule; Female; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Prospective Studies; Respiratory Tract Infections; Skin Diseases, Bacterial; Urinary Tract Infections | 1995 |
An overview of the safety of isepamicin in adults.
Topics: Adult; Aged; Anti-Bacterial Agents; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Creatinine; Dose-Response Relationship, Drug; Drug Administration Routes; Female; Gentamicins; Hearing Disorders; Humans; Kidney Diseases; Liver; Male; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 1995 |
A randomised comparison of isepamicin and amikacin in the treatment of bacterial infections in paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Administration Schedule; Enterococcus faecalis; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Staphylococcal Infections; Staphylococcus epidermidis; Streptococcal Infections | 1995 |
Pharmacokinetics of isepamicin following a single administration by intravenous infusion or intramuscular injections.
Topics: Adult; Anti-Bacterial Agents; Cross-Over Studies; Gentamicins; Humans; Infusions, Intravenous; Injections, Intramuscular; Male | 1997 |
[Combination use of second generation cephem and isepamicin for the treatment of post-surgical infection of the lower digestive tract].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefmetazole; Cefotiam; Cefuroxime; Cephalosporins; Drug Therapy, Combination; Female; Gentamicins; Humans; Intestinal Diseases; Intestines; Male; Middle Aged; Peritonitis; Postoperative Complications; Surgical Wound Infection | 1997 |
Isepamicin in intensive care unit patients with nosocomial pneumonia: population pharmacokinetic-pharmacodynamic study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Creatinine; Cross Infection; Dose-Response Relationship, Drug; Female; Gentamicins; Humans; Intensive Care Units; Kidney; Male; Middle Aged; Models, Biological; Pneumonia, Bacterial; Treatment Outcome | 1999 |
Pharmacokinetics of isepamicin during continuous venovenous hemodiafiltration.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bayes Theorem; Female; Gentamicins; Hemodiafiltration; Humans; Male; Metabolic Clearance Rate; Middle Aged | 1999 |
Isepamicin versus amikacin for the treatment of acute pyelonephritis in children.
Topics: Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Humans; Infant; Infant, Newborn; Male; Pyelonephritis; Treatment Outcome; Urine | 2000 |
Comparison of two methods to obtain a desired first isepamicin peak in intensive care patients.
Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Creatinine; Critical Care; Female; Gentamicins; Humans; Infusions, Intravenous; Intensive Care Units; Linear Models; Male; Metabolic Clearance Rate; Middle Aged; Respiration, Artificial; Treatment Outcome | 2001 |
Once daily isepamicin treatment in complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Female; Gentamicins; Humans; Male; Middle Aged; Prospective Studies; Urinary Tract Infections | 1999 |
Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Fever; Gentamicins; Humans; Male; Neoplasms; Neutropenia; Random Allocation | 2001 |
Key pharmacokinetic parameters of isepamicin in febrile neutropenic cancer patients and in women with acute pelvic inflammatory disease.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Area Under Curve; Female; Fever; Gentamicins; Hematologic Neoplasms; Humans; Infusions, Intravenous; Middle Aged; Neutropenia; Pelvic Inflammatory Disease | 2005 |
Local infusion analgesia using intra-articular double lumen catheter after total knee arthroplasty: a double blinded randomized control study.
Topics: Aged; Amides; Analgesics; Anesthetics, Local; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; C-Reactive Protein; Catheterization; Dexamethasone; Double-Blind Method; Female; Gentamicins; Glucocorticoids; Humans; Infusions, Intraosseous; Male; Middle Aged; Osteoarthritis, Knee; Pain Management; Pain Measurement; Pain, Postoperative; Ropivacaine; Treatment Outcome | 2013 |
Effects of dexamethasone on local infiltration analgesia in total knee arthroplasty: a randomized controlled trial.
Topics: Aged; Amides; Anesthetics, Local; Anti-Bacterial Agents; Anti-Inflammatory Agents; Arthroplasty, Replacement, Knee; C-Reactive Protein; Dexamethasone; Female; Gentamicins; Humans; Injections, Intra-Articular; Interleukin-6; Male; Osteoarthritis, Knee; Pain Management; Pain Measurement; Pain, Postoperative; Ropivacaine; Treatment Outcome | 2014 |
125 other study(ies) available for gentamicin and isepamicin
Article | Year |
---|---|
Comparative nephrotoxicity of SCH 21420 and amikacin in rats.
Topics: Amikacin; Animals; Creatinine; Enzymes; Gentamicins; Kanamycin; Kidney Diseases; Male; Proteinuria; Rats; Time Factors | 1979 |
In vitro studies with Sch 21420 and Sch 22591: activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Penicillin G; Sisomicin | 1978 |
In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin.
Topics: Acetyltransferases; Amikacin; Aminoglycosides; Bacteria; Drug Resistance, Microbial; Gentamicins; Kanamycin; Microbial Sensitivity Tests | 1978 |
CI-960 (PD127391 or AM-1091), sparfloxacin, WIN 57273, and isepamicin activity against clinical isolates of Mycobacterium avium-intracellularae complex, M. chelonae, and M. fortuitum.
Topics: Anti-Bacterial Agents; Fluoroquinolones; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Mycobacterium chelonae; Nontuberculous Mycobacteria; Quinolones | 1992 |
[Significance of the combined treatment with isepamicin and piperacillin in an in vitro model for complicated cystitis operated by automatic simulator apparatus for urinary concentration].
Topics: Computer Simulation; Cystitis; Drug Therapy, Combination; Gentamicins; In Vitro Techniques; Piperacillin | 1992 |
In vivo postantibiotic effect of isepamicin and other aminoglycosides in a thigh infection model in neutropenic mice.
Topics: Animals; Bacterial Infections; Disease Models, Animal; Escherichia coli; Female; Gentamicins; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Netilmicin; Neutropenia; Staphylococcus aureus; Thigh; Time Factors | 1992 |
[Fluorescence polarization immunoassay of isepamicin in blood spotted on filter paper].
Topics: Animals; Blood Specimen Collection; Filtration; Fluorescence Polarization Immunoassay; Gentamicins; Guinea Pigs; Humans | 1992 |
[Mechanisms of resistance to dactimicin and isepamicin in clinical strains of gram-negative rods isolated in Czechoslovakia].
Topics: Aminoglycosides; Anti-Bacterial Agents; Czechoslovakia; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Health Facilities | 1992 |
Increase of sensitivity to aminoglycoside antibiotics by polyamine-induced protein (oligopeptide-binding protein) in Escherichia coli.
Topics: Amino Acid Sequence; Aminoglycosides; Bacterial Proteins; Carrier Proteins; Chromosome Deletion; Escherichia coli; Escherichia coli Proteins; Gentamicins; Hydrogen-Ion Concentration; Kinetics; Lipoproteins; Magnesium; Molecular Sequence Data; Oligopeptides; Potassium; Spermidine; Structure-Activity Relationship | 1992 |
Isepamicin disposition in subjects with various degrees of renal function.
Topics: Adult; Aged; Female; Gentamicins; Humans; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Renal Dialysis | 1991 |
Effect of isepamicin dosing scheme on concentration in cochlear tissue.
Topics: Animals; Cochlea; Cochlear Nerve; Computer Simulation; Ear, Inner; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Guinea Pigs; Hearing; Male; Sensory Thresholds | 1991 |
Antimicrobial activity of isepamicin (SCH21420, 1-N-HAPA gentamicin B) combinations with cefotaxime, ceftazidime, ceftriaxone, ciprofloxacin, imipenem, mezlocillin and piperacillin tested against gentamicin-resistant and susceptible gram-negative bacilli
Topics: Cefotaxime; Ceftazidime; Culture Media; Drug Interactions; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae; Enterococcus; Gentamicins; Gram-Negative Bacteria; Imipenem; Mezlocillin; Piperacillin; Pseudomonas | 1991 |
[Combination antibacterial effects between aztreonam and eight other antibiotics].
Topics: Amoxicillin; Animals; Aztreonam; Bacterial Infections; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Female; Gentamicins; Mice; Microscopy, Phase-Contrast; Moxalactam; Proteus vulgaris; Pseudomonas aeruginosa; Serratia marcescens | 1991 |
Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection.
Topics: Amikacin; Anti-Bacterial Agents; Drug Administration Schedule; Fluorescence Polarization Immunoassay; Gentamicins; Netilmicin; Pseudomonas aeruginosa; Serratia marcescens | 1991 |
Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactams; Cilastatin; Drug Interactions; Fluorescence Polarization Immunoassay; Gentamicins; Heparin; Humans | 1991 |
Simple measurement of isepamicin, a new aminoglycoside antibiotic, in guinea pig and human plasma, using high-performance liquid chromatography with ultraviolet detection.
Topics: Animals; Chromatography, High Pressure Liquid; Gentamicins; Guinea Pigs; Humans; Radioimmunoassay; Reproducibility of Results; Ultraviolet Rays | 1991 |
Post-antibiotic effect of isepamicin compared to that of other aminoglycosides.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Staphylococcus aureus; Time Factors | 1990 |
In-vitro susceptibilities of gram-positive bacteria to cefpirome, vancomycin, isepamicin and gentamicin, singly and in combination.
Topics: Anti-Bacterial Agents; Cefpirome; Cephalosporins; Drug Therapy, Combination; Gentamicins; Gram-Positive Bacteria; Microbial Sensitivity Tests; Vancomycin | 1990 |
Column liquid chromatographic determination of isepamicin in nasal cavity using gauze.
Topics: 3-Mercaptopropionic Acid; Bacillus subtilis; Biological Assay; Chromatography, High Pressure Liquid; Gentamicins; Humans; Nasal Mucosa; o-Phthalaldehyde; Spectrometry, Fluorescence | 1990 |
[An in vitro study on combination effect of isepamicin and beta-lactam antibiotics].
Topics: Anti-Bacterial Agents; Cefoperazone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1990 |
[Pharmacokinetic and clinical studies on isepamicin in chronic complicated urinary tract infection using daily single dose treatment].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Drug Administration Schedule; Drug Evaluation; Female; Gentamicins; Humans; Infusions, Intravenous; Male; Middle Aged; Urinary Bladder Neoplasms; Urinary Tract Infections | 1990 |
Effect of dosing schedule on aminoglycoside ototoxicity: comparative cochlear ototoxicity of amikacin and isepamicin.
Topics: Amikacin; Animals; Cochlea; Drug Administration Schedule; Gentamicins; Guinea Pigs; Hair Cells, Auditory; Hair Cells, Auditory, Inner; Injections, Intramuscular; Organ of Corti; Vestibule, Labyrinth | 1990 |
High-performance liquid chromatographic determination of isepamicin in plasma, urine and dialysate.
Topics: Aminoglycosides; Analysis of Variance; Buffers; Chromatography, High Pressure Liquid; Dialysis Solutions; Gentamicins; Humans; Spectrometry, Fluorescence | 1990 |
[Determination of isepamicin in the eluates from the dried blood spots on filter paper for monitoring of blood levels in a guinea-pig].
Topics: Animals; Blood Specimen Collection; Fluorescent Antibody Technique; Gentamicins; Guinea Pigs; Injections, Intramuscular; Male; Paper | 1989 |
[Comparison of HAPA-B and amikacin in the treatment of respiratory tract infections].
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Gentamicins; Humans; Middle Aged; Respiratory Tract Infections | 1986 |
[Fundamental and clinical studies on intravenous drip infusion of HAPA-B. Intravenous Drip Infusion HAPA-B research Group].
Topics: Bacterial Infections; Gentamicins; Humans; Infusions, Intravenous | 1986 |
[Synergistic activity of isepamicin and beta-lactam antibiotics against Pseudomonas aeruginosa in vitro and in vivo].
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Drug Synergism; Drug Therapy, Combination; Gentamicins; Male; Mice; Mice, Inbred ICR; Peritonitis; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections | 1988 |
Evaluation of a fluorescence polarization immunoassay procedure for quantitation of isepamicin, a new aminoglycoside antibiotic.
Topics: Adult; Amikacin; Bilirubin; Biological Assay; Chromatography, High Pressure Liquid; Drug Interactions; Gentamicins; Hemolysis; Humans; Immunoassay; Male; Reproducibility of Results; Tobramycin | 1988 |
[Evaluation of assay methods for isepamicin sulfate (HAPA-B) in body fluids. Bioassay, HPLC and EIA methods].
Topics: Aminoglycosides; Biological Assay; Body Fluids; Chromatography, High Pressure Liquid; Gentamicins; Humans; Immunoenzyme Techniques; Kinetics | 1987 |
[Mutation frequency test for isepamicin (HAPA-B)].
Topics: Escherichia coli; Gentamicins; Mutagenicity Tests; Mutation; Salmonella typhimurium | 1986 |
[Toxicological studies on isepamicin (HAPA-B). I. Acute toxicity test in the mouse, rat and dog].
Topics: Administration, Oral; Amikacin; Animals; Dogs; Female; Gentamicins; Injections, Intramuscular; Injections, Intravenous; Lethal Dose 50; Male; Mice; Rats | 1986 |
[Toxicological studies on isepamicin (HAPA-B). II. Intramuscular subacute toxicity test in the rat].
Topics: Amikacin; Animals; Body Weight; Dose-Response Relationship, Drug; Female; Gentamicins; Injections, Intramuscular; Kidney; Male; Rats | 1986 |
[Toxicological studies on isepamicin (HAPA-B). IV. Intramuscular subacute toxicity test in the dog].
Topics: Amikacin; Animals; Dogs; Dose-Response Relationship, Drug; Female; Gentamicins; Injections, Intramuscular; Kidney; Male; Organ Size | 1986 |
[Toxicological studies on isepamicin (HAPA-B). VII. Chronic intramuscular test in the rat].
Topics: Amikacin; Animals; Blood Chemical Analysis; Dose-Response Relationship, Drug; Female; Gentamicins; Injections, Intramuscular; Kidney; Male; Organ Size; Rats | 1986 |
[Effect of isepamicin (HAPA-B) on reproduction. I. Fertility study in rats (intramuscular administration)].
Topics: Animals; Body Weight; Female; Fertility; Gentamicins; Injections, Intramuscular; Male; Pregnancy; Pregnancy, Animal; Rats | 1986 |
[Effect of isepamicin (HAPA-B) on reproduction. II. Teratological study in rats (intramuscular administration)].
Topics: Abnormalities, Drug-Induced; Animals; Female; Fertility; Fetus; Gentamicins; Injections, Intramuscular; Male; Pregnancy; Pregnancy, Animal; Rats | 1986 |
[Effect of isepamicin (HAPA-B) on reproduction. IV. Peri- and post-natal study in rats (intramuscular administration)].
Topics: Animals; Animals, Newborn; Behavior, Animal; Body Weight; Feeding Behavior; Female; Gentamicins; Injections, Intramuscular; Male; Pregnancy; Pregnancy, Animal; Rats | 1986 |
[Immunological properties of isepamicin (HAPA-B)].
Topics: Animals; Antibody Formation; Cross Reactions; Gentamicins; Guinea Pigs; Immunoglobulin E; Immunoglobulin G; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Rabbits | 1986 |
[Mutagenicity tests for isepamicin (HAPA-B)].
Topics: Animals; Cells, Cultured; Chromosome Aberrations; Cricetinae; Cricetulus; DNA Repair; Gentamicins; Mutagenicity Tests; Mutation; Salmonella | 1986 |
[Local irritation study with isepamicin].
Topics: Animals; Atrophy; Blood Vessels; Edema; Fibrosis; Gentamicins; Hemorrhage; Injections, Intramuscular; Male; Muscles; Necrosis; Rabbits | 1986 |
[The neuromuscular blocking activity of isepamicin sulfate (HAPA-B) compared with other aminoglycoside antibiotics].
Topics: Amikacin; Aminoglycosides; Animals; Dose-Response Relationship, Drug; Gentamicins; In Vitro Techniques; Infusions, Intravenous; Male; Neuromuscular Blocking Agents; Rats; Rats, Inbred Strains | 1987 |
[General pharmacological studies on isepamicin sulfate (HAPA-B)].
Topics: Aminoglycosides; Anesthetics, Local; Animals; Autonomic Nervous System; Blood Coagulation; Cats; Central Nervous System; Digestive System; Dogs; Female; Gentamicins; Guinea Pigs; Hemodynamics; In Vitro Techniques; Male; Mice; Rabbits; Rats; Respiration; Urogenital System | 1987 |
[Studies on the metabolic fate of isepamicin sulfate (HAPA-B). I. Absorption, distribution, metabolism and excretion in rats].
Topics: Aminoglycosides; Animals; Female; Gentamicins; Half-Life; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1987 |
[Studies on the metabolic fate of isepamicin sulfate (HAPA-B). II. Accumulation of HAPA-B after multiple administration in rats].
Topics: Aminoglycosides; Animals; Gentamicins; Injections, Intramuscular; Injections, Intravenous; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1987 |
[Studies on the metabolic fate of isepamicin sulfate (HAPA-B). III. Intramuscular, intravenous and drip intravenous administration of HAPA-B in rabbits].
Topics: Aminoglycosides; Animals; Gentamicins; Infusions, Intravenous; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male; Models, Biological; Rabbits; Tissue Distribution | 1987 |
[Studies on the metabolic fate of isepamicin sulfate (HAPA-B). IV. Intramuscular, intravenous and drip intravenous administration of HAPA-B in dogs].
Topics: Aminoglycosides; Animals; Dogs; Gentamicins; Infusions, Intravenous; Injections, Intramuscular; Injections, Intravenous; Kinetics; Male; Models, Biological | 1987 |
[Studies on the metabolic fate of isepamicin sulfate (HAPA-B). V. Plasma concentrations of HAPA-B in dogs after multiple administrations].
Topics: Amikacin; Aminoglycosides; Animals; Dogs; Female; Gentamicins; Injections, Intramuscular; Kinetics; Male; Models, Biological | 1987 |
[Metabolic fate of 14C-isepamicin sulfate (14C-HAPA-B) in rats. I. Absorption, distribution, metabolism and excretion after a single intramuscular and intravenous administration].
Topics: Aminoglycosides; Animals; Autoradiography; Blood Proteins; Carbon Radioisotopes; Gentamicins; Injections, Intramuscular; Injections, Intravenous; Male; Protein Binding; Rats; Rats, Inbred Strains; Tissue Distribution | 1987 |
[Metabolic fate of 14C-isepamicin sulfate (14C-HAPA-B) in rats. II. Distribution and excretion after the successive administration].
Topics: Aminoglycosides; Animals; Autoradiography; Carbon Radioisotopes; Gentamicins; Injections, Intramuscular; Male; Rats; Rats, Inbred Strains; Tissue Distribution | 1987 |
[Metabolic fate of 14C-isepamicin sulfate (14C-HAPA-B) in rats. III. Placental transfer and excretion into milk].
Topics: Aminoglycosides; Animals; Autoradiography; Carbon Radioisotopes; Female; Fetus; Gentamicins; Maternal-Fetal Exchange; Milk; Placenta; Pregnancy; Rats; Rats, Inbred Strains; Tissue Distribution | 1987 |
Activity of amikacin, gentamicin and Schering 21420 when combined with carbenicillin or piperacillin against Pseudomonas aeruginosa.
Topics: Amikacin; Aminoglycosides; Carbenicillin; Drug Synergism; Gentamicins; Penicillins; Piperacillin; Pseudomonas aeruginosa | 1982 |
Comparative study of the effects of sagamicin, 1 N-HABA-sagamicin, UK-4, Sch 21420, gentamicin and amikacin on the respiration activity of isolated rat kidney mitochondria.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Gentamicins; In Vitro Techniques; Kanamycin; Kidney; Mitochondria; Oxygen Consumption; Rats; Structure-Activity Relationship | 1980 |
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Drug Resistance, Microbial; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Sisomicin; Tobramycin | 1980 |
Interpretive standards for disk susceptibility tests with Sch 21420 and amikacin.
Topics: Amikacin; Bacteria; Gentamicins; Kanamycin; Microbial Sensitivity Tests; Regression Analysis | 1980 |
[Reevaluation of current antimicrobials. Series 25: isepamicin].
Topics: Bacterial Infections; Cystitis; Gentamicins; Humans; Microbial Sensitivity Tests; Respiratory Tract Infections | 1995 |
[Post-antibiotic effect of three aminoglycosides against Klebsiella pneumoniae].
Topics: Amikacin; Dose-Response Relationship, Drug; Filtration; Gentamicins; In Vitro Techniques; Klebsiella pneumoniae; Netilmicin | 1994 |
[Bactericidal activities of isepamicin and ofloxacin against Pseudomonas aeruginosa evaluated using an in vitro pharmacokinetic simulation system].
Topics: Adult; Computer Simulation; Drug Synergism; Gentamicins; Humans; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa | 1994 |
[Antibacterial activities of isepamicin against fresh clinical isolates of gram-negative bacilli].
Topics: Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests | 1994 |
Serotypes and extended spectrum beta-lactam resistance in aminoglycoside resistant Pseudomonas aeruginosa isolates from two Belgian general hospitals: a seven year study.
Topics: Amikacin; Anti-Bacterial Agents; Belgium; beta-Lactams; Cross Infection; Drug Resistance, Microbial; Gentamicins; Hospitals; Humans; Pseudomonas aeruginosa; Serotyping | 1993 |
Activity of isepamicin and selection of permeability mutants to beta-lactams during aminoglycoside therapy of experimental endocarditis due to Klebsiella pneumoniae CF104 producing an aminoglycoside acetyltransferase 6' modifying enzyme and a TEM-3 beta-l
Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactamases; beta-Lactams; Cell Membrane Permeability; Disease Models, Animal; Drug Therapy, Combination; Endocarditis; Female; Gentamicins; Klebsiella pneumoniae; Mutation; Rabbits | 1994 |
Influence of circadian-stage-dependent dosing schedule on nephrotoxicity and pharmacokinetics of isepamicin in rats.
Topics: Animals; Anti-Bacterial Agents; Circadian Rhythm; Gentamicins; Injections, Subcutaneous; Kidney Diseases; Rats; Rats, Wistar | 1993 |
Effect of hemodialysis on serum concentration of isepamicin in a patient with endstage renal failure.
Topics: Aged; Gentamicins; Half-Life; Humans; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Renal Dialysis | 1993 |
Population pharmacokinetic analysis of new aminoglycosides, astromicin and isepamicin, and evaluation of Bayesian prediction method for approximation of individual clearance of drug.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Bayes Theorem; Gentamicins; Humans; Male; Metabolic Clearance Rate; Middle Aged | 1993 |
Pharmacokinetics and metabolism of 14C-isepamicin in humans following intravenous administration.
Topics: Adult; Anti-Bacterial Agents; Carbon Radioisotopes; Gentamicins; Humans; Injections, Intravenous; Male | 1995 |
Isepamicin Once a Day--Enhancing Traditional Aminoglycoside Therapy. Proceedings of a meeting. Rotherwick, England, September 24-25, 1994.
Topics: Anti-Bacterial Agents; Gentamicins; Humans | 1995 |
The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin--a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups.
Topics: Acetyltransferases; Anti-Bacterial Agents; Carbohydrate Sequence; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Sequence Data | 1995 |
Pharmacokinetics of isepamicin in paediatric patients.
Topics: Adolescent; Aging; Anti-Bacterial Agents; Child; Child, Preschool; Gentamicins; Humans; Infant; Infant, Newborn; Microbial Sensitivity Tests | 1995 |
Auditory impairment in guinea pigs treated with isepamicin.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Auditory Threshold; Body Weight; Brain; Cochlear Duct; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Evoked Potentials, Auditory, Brain Stem; Gentamicins; Guinea Pigs; Hair Cells, Auditory; Hearing Disorders; Male; Microscopy, Electron, Scanning | 1995 |
Aminoglycoside antibiotics prevent the formation of non-bilayer structures in negatively-charged membranes. Comparative studies using fusogenic (bis(beta-diethylaminoethylether)hexestrol) and aggregating (spermine) agents.
Topics: Animals; Anti-Bacterial Agents; Electrochemistry; Gentamicins; Hexestrol; In Vitro Techniques; Kidney; Liposomes; Magnetic Resonance Spectroscopy; Membrane Fusion; Membrane Lipids; Molecular Conformation; Spermine; Thermodynamics | 1996 |
[Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus].
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefazolin; Cefotiam; Cephalosporins; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gentamicins; Humans; Methicillin Resistance; Staphylococcus aureus | 1996 |
[Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 3. The results against Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Drug Therapy, Combination; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1996 |
Population pharmacokinetic study of isepamicin with intensive care unit patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Gentamicins; Humans; Intensive Care Units; Linear Models; Middle Aged | 1996 |
Temporal variation in nephrotoxicity of low doses of isepamicin in rats.
Topics: Animals; Anti-Bacterial Agents; Body Weight; Circadian Rhythm; Gentamicins; Immunohistochemistry; Injections, Intraperitoneal; Kidney Cortex; Kidney Diseases; Kidney Tubules, Proximal; Male; Microscopy, Electron; Rats; Rats, Sprague-Dawley; Regeneration; Thymidine; Time Factors | 1996 |
[Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 2. The results against enterobacteriaceae].
Topics: Anti-Bacterial Agents; beta-Lactams; Drug Synergism; Enterobacter cloacae; Enterobacteriaceae; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests | 1996 |
Resistance to amikacin and isepamicin in rabbits with experimental endocarditis of an aac(6')-Ib-bearing strain of Klebsiella pneumoniae susceptible in vitro.
Topics: Acetyltransferases; Amikacin; Animals; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Microbial; Endocarditis; Female; Genes, Bacterial; Gentamicins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Rabbits | 1996 |
Analysis of isepamicin in human plasma by radioimmunoassay, microbiologic assay, and high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Biological Assay; Chromatography, High Pressure Liquid; Drug Monitoring; Gentamicins; Humans; Radioimmunoassay | 1997 |
Single-dose pharmacokinetics of isepamicin in young and geriatric volunteers.
Topics: Adult; Age Factors; Aged; Anti-Bacterial Agents; Area Under Curve; Female; Gentamicins; Humans; Male; Metabolic Clearance Rate; Middle Aged; Sex Factors | 1997 |
Solution studies of isepamicin and conformational comparisons between isepamicin and butirosin A when bound to an aminoglycoside 6'-N-acetyltransferase determined by NMR spectroscopy.
Topics: Acetyltransferases; Binding Sites; Butirosin Sulfate; Enterococcus faecium; Gentamicins; Kinetics; Magnetic Resonance Spectroscopy; Protein Conformation; Solutions; Substrate Specificity | 1998 |
Postanitbiotic and sub-MIC effects of azithromycin and isepamicin against Staphylococcus aureus and Escherichia coli.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Escherichia coli; Female; Gentamicins; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Staphylococcus aureus | 1998 |
[Sensitivity of Pseudomonas aeruginosa to amikacin and to isepamicin in surgery and in intensive care].
Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Gentamicins; Humans; Intensive Care Units; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Surgery Department, Hospital | 1997 |
Treatment of osteomyelitis with antibiotic-soaked porous glass ceramic.
Topics: Adult; Animals; Anti-Bacterial Agents; Apatites; Arthroplasty, Replacement, Hip; Calcium Compounds; Cefmetazole; Cephamycins; Ceramics; Drug Delivery Systems; Drug Implants; Drug Therapy, Combination; Durapatite; Female; Femur; Gentamicins; Glass; Hip Prosthesis; Humans; Male; Middle Aged; Osteomyelitis; Pilot Projects; Porosity; Prosthesis-Related Infections; Rabbits; Silicates; Tibia; Time Factors | 1998 |
Protective effect of ceftriaxone against the nephrotoxicity of isepamicin administered once daily in rats.
Topics: Animals; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Creatinine; Gentamicins; Hexosaminidases; Kidney Cortex; Kidney Diseases; Male; Rats; Rats, Wistar | 1998 |
Relationship between spontaneous aminoglycoside resistance in Escherichia coli and a decrease in oligopeptide binding protein.
Topics: Amino Acids; Anti-Bacterial Agents; Bacterial Proteins; Biological Transport; Carrier Proteins; Down-Regulation; Escherichia coli; Escherichia coli Proteins; Gentamicins; Kanamycin; Kanamycin Resistance; Lipoproteins; Mutagenesis; Peptides; Polyamines | 1998 |
Antibiotic-loaded porous hydroxyapatite blocks for the treatment of osteomyelitis and postoperative infection. A preliminary report.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Biocompatible Materials; Combined Modality Therapy; Curettage; Drug Implants; Durapatite; Female; Follow-Up Studies; Gentamicins; Humans; Infusions, Intravenous; Joint Prosthesis; Male; Osteomyelitis; Porosity; Prosthesis-Related Infections; Radiography; Treatment Outcome | 1998 |
Rabbits treated with chronic isepamicin are resistant to mivacurium and rocuronium.
Topics: Androstanols; Animals; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Synergism; Female; Gentamicins; Isoquinolines; Male; Mivacurium; Neuromuscular Nondepolarizing Agents; Rabbits; Rocuronium | 1999 |
[Effects of isepamicin and beta-lactam antibiotics on the release of endotoxin from Pseudomonas aeruginosa].
Topics: Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Endotoxins; Gentamicins; Imipenem; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins | 1999 |
[Neuromuscular blocking properties of arbekacin, astromicin, isepamicin and netilmicin in the rabbit].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Dibekacin; Dose-Response Relationship, Drug; Gentamicins; Netilmicin; Neuromuscular Blocking Agents; Rabbits; Tubocurarine | 1999 |
Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Apoptosis; Blood Urea Nitrogen; Cell Division; Creatinine; Female; Gentamicins; In Situ Nick-End Labeling; Kidney Cortex; Kidney Tubules, Proximal; Netilmicin; Phospholipids; Rats; Rats, Wistar | 2000 |
[The resistance of recent clinical isolates against isepamycin, other aminoglycosides and injectable beta-lactams].
Topics: Amikacin; Anti-Bacterial Agents; Bacteria; Ceftazidime; Dibekacin; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Piperacillin; Tobramycin | 2000 |
[In vitro interaction of piperacillin and imipenem/cilastatin combined with aminoglycosides against Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Imipenem; Netilmicin; Penicillins; Piperacillin; Pseudomonas aeruginosa; Tobramycin | 2000 |
Determination of isepamicin sulfate and related compounds by high performance liquid chromatography using evaporative light scattering detection.
Topics: Anti-Bacterial Agents; Carbohydrate Conformation; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Gentamicins; Light; Molecular Sequence Data; Reproducibility of Results; Scattering, Radiation; Sensitivity and Specificity | 2001 |
[Concentration of isepamicin sulfate in bone marrow blood].
Topics: Adult; Aged; Anti-Bacterial Agents; Biological Transport; Bone Marrow; Female; Gentamicins; Humans; Infusions, Intravenous; Male; Middle Aged; Rotator Cuff; Rotator Cuff Injuries; Surgical Wound Infection; Time Factors | 2000 |
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Stenotrophomonas maltophilia; Time Factors | 2001 |
Cloning, overexpression, and purification of aminoglycoside antibiotic nucleotidyltransferase (2'')-Ia: conformational studies with bound substrates.
Topics: Bacterial Proteins; Binding Sites; Cloning, Molecular; Escherichia coli; Gene Expression Regulation, Bacterial; Gentamicins; Kanamycin; Kanamycin Resistance; Nuclear Magnetic Resonance, Biomolecular; Nucleotidyltransferases; Protein Binding; Protein Conformation; Pseudomonas aeruginosa; RNA, Bacterial; Substrate Specificity | 2001 |
Neuromuscular blocking effects of the aminoglycoside antibiotics arbekacin, astromicin, isepamicin and netilmicin on the diaphragm and limb muscles in the rabbit.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Diaphragm; Dibekacin; Dose-Response Relationship, Drug; Gentamicins; In Vitro Techniques; Male; Muscle Contraction; Muscle, Skeletal; Netilmicin; Neuromuscular Junction; Rabbits | 2001 |
[In vitro interaction of tazobactam/piperacillin combined with aminoglycosides against Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli AND Staphylococcus aureus].
Topics: Amikacin; Anti-Bacterial Agents; Drug Antagonism; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus; Tazobactam | 2002 |
Protective effect of fleroxacin against the nephrotoxicity of isepamicin in rats.
Topics: Acetylglucosaminidase; Animals; Blood Urea Nitrogen; Creatinine; Drug Therapy, Combination; Fleroxacin; Gentamicins; Kidney; Kidney Tubular Necrosis, Acute; Kidney Tubules, Proximal; Male; Rats; Rats, Wistar | 2002 |
Diffusion of isepamicin into cancellous and cortical bone tissue.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Biological Availability; Bone and Bones; Female; Gentamicins; Hip; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged | 2002 |
[Antibacterial activities and PK/PD parameters of aminoglycosides against recent clinical isolates of gram-negative rods].
Topics: Amikacin; Anti-Bacterial Agents; Dibekacin; Drug Resistance, Microbial; Gentamicins; Gram-Negative Bacteria; Humans; Netilmicin; Tobramycin | 2002 |
[Iliopsoas abscess accompanied by epidural abscess--a case report].
Topics: Anti-Bacterial Agents; Drainage; Epidural Abscess; Gentamicins; Humans; Low Back Pain; Magnetic Resonance Imaging; Male; Middle Aged; Psoas Abscess; Treatment Outcome | 2003 |
A case of Pasteurella haemolytica sepsis in a patient with mitral valve disease who developed a splenic abscess.
Topics: Abscess; Adult; Anti-Bacterial Agents; Gentamicins; Humans; Male; Mannheimia haemolytica; Pasteurellaceae Infections; Spleen; Splenic Diseases | 2003 |
Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells.
Topics: Amino Acid Substitution; B-Lymphocytes; Calcium; Calcium Signaling; Cell Division; Cell Line, Transformed; Codon, Nonsense; Endoplasmic Reticulum; Gentamicins; Humans; Ion Transport; Kidney; Membrane Proteins; Mutation, Missense; Organ Specificity; Platelet Activating Factor; Point Mutation; Polycystic Kidney, Autosomal Dominant; Proteins; RNA, Messenger; Suppression, Genetic; TRPP Cation Channels | 2004 |
High release of antibiotic from a novel hydroxyapatite with bimodal pore size distribution.
Topics: Adsorption; Animals; Anti-Bacterial Agents; Cephalosporins; Delayed-Action Preparations; Drug Carriers; Durapatite; Female; Femur; Gentamicins; Microscopy, Electron, Scanning; Nanostructures; Porosity; Prostheses and Implants; Rabbits; Vancomycin | 2004 |
[Aminoglycoside resistance in gramnegative pathogens of nosocomial infections in Russia].
Topics: Acetyltransferases; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infection Control; Nucleotidyltransferases; Phosphotransferases; Russia; Substrate Specificity | 2004 |
A case of pneumonia caused by Ewingella americana in a patient with chronic renal failure.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Enterobacteriaceae; Enterobacteriaceae Infections; Gentamicins; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Pneumonia; Sputum; Time Factors | 2005 |
In vitro activity of isepamicin against Pseudomomas aeruginosa and Enterobacter cloacae strains resistant to amikacin: a preliminary report.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterobacter cloacae; Gentamicins; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1989 |
In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Gentamicins; Hospitals, University; Microbial Sensitivity Tests; Minocycline; Taiwan; Tigecycline | 2005 |
[Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Bacterial Proteins; Gentamicins; Mice; Mice, Inbred Strains; Mutation; Plague; Yersinia pestis | 2005 |
In Vitro activities of isepamicin, other aminoglycosides, and capreomycin against clinical isolates of rapidly growing mycobacteria in Taiwan.
Topics: Aminoglycosides; Anti-Bacterial Agents; Capreomycin; Gentamicins; Humans; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium fortuitum; Nontuberculous Mycobacteria | 2007 |
In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Cross Infection; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Taiwan | 2007 |
Research and clinical value of antibacterial-application software.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gentamicins; Humans; Imipenem; Isosorbide Dinitrate; Male; Ofloxacin; Software | 2008 |
Apoptosis induced by aminoglycosides in LLC-PK1 Cells: comparative study of neomycin, gentamicin, amikacin, and isepamicin using electroporation.
Topics: Amikacin; Aminoglycosides; Animals; Anti-Bacterial Agents; Apoptosis; Electroporation; Gentamicins; LLC-PK1 Cells; Neomycin; Swine | 2008 |
Determination of isepamicin in human plasma by HPLC with fluorescence detection after derivatization using 6-aminoquinolyl-N-hydroxysuccinimidyl-carbamate.
Topics: Amikacin; Aminoquinolines; Anti-Bacterial Agents; Carbamates; Carbohydrate Sequence; Chromatography, High Pressure Liquid; Gentamicins; Humans; Indicators and Reagents; Molecular Sequence Data; Reproducibility of Results; Spectrometry, Fluorescence | 2008 |
Prophylactic use of isepamicin and levofloxacin for transrectal prostate biopsy: a retrospective single center study.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Infections; Biopsy; Drug Therapy, Combination; Gentamicins; Humans; Levofloxacin; Male; Ofloxacin; Prostate; Prostatitis; Rectum; Retrospective Studies; Risk Factors; Ultrasound, High-Intensity Focused, Transrectal | 2009 |
Mutant APH(2'')-IIa enzymes with increased activity against amikacin and isepamicin.
Topics: Aged; Amikacin; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Directed Molecular Evolution; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Gentamicins; Humans; Kinetics; Models, Molecular; Molecular Sequence Data; Mutagenesis; Mutation; Phosphotransferases (Alcohol Group Acceptor); Protein Structure, Tertiary; Recombinant Proteins; Sequence Homology, Amino Acid | 2010 |
Antibiotic and synergistic effect of Leu-Lys rich peptide against antibiotic resistant microorganisms isolated from patients with cholelithiasis.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Line; Cephalosporins; Cholelithiasis; Drug Resistance, Bacterial; Drug Synergism; Gentamicins; Humans; Melitten; Molecular Sequence Data; Pseudomonas aeruginosa | 2010 |
In vitro susceptibility of nosocomial isolates against a new aminoglycoside isepamicin.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cross Infection; Drug Resistance, Bacterial; Gentamicins; Humans; In Vitro Techniques; India; Microbial Sensitivity Tests | 2001 |
Necrotic intramuscular chloroma with infection: magnetic resonance imaging features.
Topics: Anti-Bacterial Agents; Antimetabolites, Antineoplastic; Child; Contrast Media; Cytarabine; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Gentamicins; Humans; Image Enhancement; Klebsiella Infections; Klebsiella pneumoniae; Leg; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Meropenem; Muscle Neoplasms; Necrosis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sarcoma, Myeloid; Teicoplanin; Thienamycins; Treatment Outcome | 2011 |
In vitro antimicrobial susceptibility to isepamicin of 6,296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece.
Topics: Anti-Infective Agents; Enterobacteriaceae; Gentamicins; Greece; Humans; Microbial Sensitivity Tests | 2012 |
Antimicrobial susceptibility of non-fermenting Gram-negative isolates to isepamicin in a region with high antibiotic resistance.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Greece; Humans; Microbial Sensitivity Tests; Prevalence | 2012 |
In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan.
Topics: Acinetobacter baumannii; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Burkholderia cepacia; Cross Infection; Drug Resistance, Bacterial; Gentamicins; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; Tobramycin | 2016 |
In vitro activity of aminoglycosides, clofazimine, d-cycloserine and dapsone against 83 Mycobacterium avium complex clinical isolates.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Cycloserine; Drug Synergism; Fluoroquinolones; Gentamicins; Humans; Linezolid; Microbial Sensitivity Tests; Microbial Viability; Moxifloxacin; Mycobacterium avium; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum; Streptomycin | 2018 |
Complete reconstitution of the diverse pathways of gentamicin B biosynthesis.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; Biosynthetic Pathways; Gene Expression; Gentamicins; Glycosyltransferases; Micromonospora; Substrate Specificity | 2019 |
Efficacy of combined prophylactic use of levofloxacin and isepamicin for transrectal prostate needle biopsy: A retrospective single-center study.
Topics: Acute Disease; Administration, Intravenous; Administration, Oral; Aged; Antibiotic Prophylaxis; Bacteria; Biopsy, Large-Core Needle; Drug Therapy, Combination; Gentamicins; Humans; Incidence; Levofloxacin; Male; Postoperative Complications; Prostate; Prostatic Neoplasms; Prostatitis; Rectum; Retrospective Studies; Ultrasonography, Interventional | 2019 |
Investigation of isepamicin in vitro efficiency in Gram negative bacteria efficacy of isepamicin.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Carbapenems; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Netilmicin; Pseudomonas aeruginosa; Tobramycin | 2021 |